eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.（EFTR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
eftr · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$5.50
+2749900.0% upside
Low
$1.00
Median: $5.5 · Last Close: $0.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.00 | ↑ 0.00% |
1-day model range: $0–$0. Peak: $0 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EFTR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-03-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-25 | Stifel | Upgrade ↑ | Hold→Buy |
| 2023-05-09 | Credit Suisse | Maintains | Outperform→Outperform |
| 2023-03-08 | Credit Suisse | Maintains | Outperform→Outperform |
| 2023-01-08 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-01-05 | Credit Suisse | Maintains | Outperform→Outperform |
| 2022-11-16 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2022-08-10 | JMP Securities | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on eFFECTOR Therapeutics, Inc. (EFTR) stock. Of the recent 20 rating actions, 2 were upgrades and 1 were downgrades. 6 analysts currently cover EFTR.
分析师推荐趋势
EFTR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-12.42
EPS Next Year
$-6.17
↓ 50.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast EFTR EPS of $-12.42 for the current fiscal year, based on estimates from 1 analysts. The EFTR revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EFTR 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EFTR 的共识目标价为 $5.50（+2749900.0% 上行空间），分析师共识为 Buy。
EFTR 的短期预测（明日）为 $0.00（+0.00%）。
eFFECTOR Therapeutics, Inc. 在 OTC 上市，代码 EFTR。EFTR 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
EFTR 预测 · 8 个问题根据 6 位华尔街分析师，EFTR 的 12 个月平均目标价为 $5.50，最高 $10.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +2749900.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.